Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

23,104 total articles

RBC Cuts DOW Price Target by 45% and Lowers Rating, Citing Short-Lived Price Tailwinds and Heavy Alberta Capex

RBC Cuts DOW Price Target by 45% and Lowers Rating, Citing Short-Lived Price Tailwinds and Heavy Alberta Capex

RBC Capital Markets lowered its rating on Dow from Outperform to Sector Perform and reduced the price target to $28 from $51. The brokerage argued that a recent uptick in polyethylene prices is unlikely to persist, and that Dow's planned Alberta petrochemicals expansion will absorb a substantial portion of the company's free cash flow through 2030.…

Alcoa Shares Drop After $4.1 Billion Purchase of South32 Aluminum Assets

Alcoa Shares Drop After $4.1 Billion Purchase of South32 Aluminum Assets

Alcoa shares tumbled in pre-market trading after the company announced a roughly $4.1 billion agreement to acquire South32's aluminum value-chain assets. The consideration mixes $3.1 billion in cash and about 17 million newly issued Alcoa shares, and the transaction carries a contingent payment feature that could add up to $750 million. Analysts no…

BYD Poised to Reclaim Lead in Global Battery-Electric Vehicle Sales

BYD Poised to Reclaim Lead in Global Battery-Electric Vehicle Sales

BYD reported 557,090 battery-electric vehicle deliveries in the second quarter, positioning it to retake the global BEV sales crown from Tesla, which is expected to disclose roughly 396,500 vehicle sales next week. BYD's broader sales mix rose in June, while the company accelerates technology and production moves as competition and price pressure i…

Citi Elevates Lockheed Martin, Puts Karman Holdings on 90-Day Catalyst Watch as 'Defense Now' Thesis Gains Traction

Citi Elevates Lockheed Martin, Puts Karman Holdings on 90-Day Catalyst Watch as 'Defense Now' Thesis Gains Traction

Citi analyst John Godyn raised Lockheed Martin to Buy with a $582 target and opened a positive 90-day catalyst watch on Karman Holdings while updating his tactical framework from 'Aerospace First, Defense Next' to 'Defense Now.' Godyn cited valuation, improving fundamentals and exposure to growth themes for Lockheed, and highlighted valuation compr…

Swedish Court Orders Google to Pay About 14.3 Billion SEK to Klarna's PriceRunner in Antitrust Ruling

Swedish Court Orders Google to Pay About 14.3 Billion SEK to Klarna's PriceRunner in Antitrust Ruling

A Stockholm court on July 1 ruled that Alphabet’s Google must pay the equivalent of about 14.3 billion Swedish crowns (roughly $1.5 billion) in antitrust damages to PriceRunner, the price comparison business linked to Klarna. The court concluded PriceRunner suffered harm after Google illegally favoured its own price comparison product. PriceRunner …

General Mills Tops Q4 Estimates as At-Home Eating Strengthens Demand

General Mills Tops Q4 Estimates as At-Home Eating Strengthens Demand

General Mills reported fourth-quarter adjusted earnings per share of $0.95 and sales of $4.61 billion, beating analyst expectations. The company said stronger demand for pantry staples and breakfast cereals, driven by consumers choosing to eat at home amid persistent inflation and rising living costs, supported results. Shares, which have fallen 25…

ServiceNow Shares Rise After Guggenheim Upgrades Stock to Buy

ServiceNow Shares Rise After Guggenheim Upgrades Stock to Buy

ServiceNow stock climbed about 4% following an upgrade from Guggenheim analyst John DiFucci, who moved the rating from Neutral to Buy and assigned a $125 price target. The new valuation equates to 7.5x EV/NTM Recurring Revenue, a premium to many SaaS peers that Guggenheim says is justified. The firm highlighted expected improvements in the U.S. Fed…

Medicare Pilot Expands Access to GLP-1 Weight-Loss Drugs for Older Americans - Who Qualifies and What Are the Concerns?

Medicare Pilot Expands Access to GLP-1 Weight-Loss Drugs for Older Americans - Who Qualifies and What Are the Concerns?

A Medicare pilot beginning July 1 will make GLP-1 weight-loss medications available to many beneficiaries 65 and older or with disabilities for a $50 monthly co-pay. The demonstration covers branded injections and pills from Novo Nordisk and Eli Lilly through the end of 2027, but clinicians and policy experts warn of clinical risks for older adults…